+499.5%
MRNA vs CLBK
+73.3%
+426.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CLBK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | 0.0% | -2.2% | -2.2% |
| 7D | +5.5% | +1.2% | +4.3% | +5.8% |
| 30D | +158.7% | +9.1% | +149.6% | +155.6% |
| 3M | +182.1% | +27.7% | +154.4% | +172.8% |
| 6M | +151.8% | +40.8% | +111.0% | +140.4% |
| YTD | +393.6% | +66.4% | +327.2% | +362.3% |
| 1Y | +499.5% | +72.4% | +427.1% | +454.9% |
| All | +499.5% | +73.3% | +426.2% | +454.9% |
Cumulative growth
Daily Returns
Daily percentage return beside CLBK.
Daily Out/Under-Performance
Portfolio return minus CLBK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CLBK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CLBK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling